[PDF] Top 20 Brain repair: cell therapy in stroke

... IV therapy than for more invasive delivery routes since there are procedural complications from either IA or direct intracerebral ...the brain) may depend on the stage of research and the procedural ... See full document

... In stroke trIAl The Pilot Investigation of Stem Cells in Stroke (PISCES) trial also evaluated intraparenchymal cell therapy for chronic stroke, using cells derived from human fetal ... See full document

... of cell therapy for stroke after BMSCs, hUCBs and ...injured brain tissue [242, 243] and improve the motor function and neurological outcomes of experimental stroke ani- mals [242, ... See full document

... stem cell trials completed to date means that it is difficult to make any meaningful comparisons between ...The Stroke Therapy Academic Industry Roundtable (STAIR) II meeting elucidated the important ... See full document

... transient stroke have demonstrated increased cerebral ischemia – reperfusion-induced blood – brain barrier (BBB) disruption and neurovascular damage [11, 50 – ...of cell therapy, hAD-MSCs only ... See full document

... from stroke is ultimately a result of mass cell death and tissue loss in the ...lost brain cells through neurogenesis is an obvious therapeutic mechanism of NSC transplantation in the chronic phase ... See full document

... Many different mechanisms have been so far proposed to explain functional recovery after stem cells transplantation. Functional integration into host circuit, replacement of lost circuits, neuroprotection, reduced ... See full document

... direct cell death pathway between is- chemic stroke and cardiac failure in order to further the development of innovative treatments that address both diseases [14, ...a stroke, high levels of ... See full document

... of cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well ...best cell type to be used or the best methodology for the ... See full document

... HR repair in several cancer and non-cancer cell model ...HR repair of ...DSB repair was attenuated, and tumor cytotoxicity response to the PARP inhibitor ABT-888 was significantly increased ... See full document

... include cell replacement, growth factor secretion, and biobridge formation ...[59]. Stroke therapeutics have been categorized as ‘neuroprotective’ for the acute phase or ‘neuroregenerative’ for the subacute ... See full document

... es. 2 Despite proved efficacy of some therapy, the number of patients treated for acute stroke remains disappointingly low. Intravenous tPA. tPA is the only drug currently authorized by the FDA for acute ... See full document

... Introduction: Stroke is a major cause of permanent neurologic damage, with few effective treatments available to restore lost ...all cell types in vitro and can be generated from a stroke ...in ... See full document

... stem cell biology. However, traditional cell-based therapeutics have many limitations, one of which is their harmful effects exhibited on healthy body cells due to their lack of ...effective ... See full document

... Cognitive impairment is an important aspect to consider in regard to the assessment of the impact and morbidity of a primary brain tumour. Improved awareness of the potential cognitive effects in relation to ... See full document

... Acute ischemic strokes are the third leading cause of death and the leading cause of neurological disability worldwide. The oxygen and glucose deprivation associated with ischemic strokes not only leads to neuronal ... See full document

... after stroke, result- ing in a failure to report or respond to stimulation in contralesional hemispace (25-30% of all stroke patients, ...of stroke patients suffering from neglect is worse than that ... See full document

... sequential therapy of gefitinib and ...with brain lesions, and disruption of the BBB in BM may be more severe than that in the surrounding ...the brain tumor in study of CNS pharmacokinetics of ... See full document

... A successful imaging system needs to have suffi- cient signal sensitivity to detect grafted cells and suf- ficient spatial resolution to determine their location within the tissue/organ. The data presented in this ... See full document

... genetically engineered cells producing labeled EVs or exogenous EVs previously labeled are used. The EVs biogenesis is also demonstrated, beginning with endocytosis and ending with the release of the EVs via exocytosis. ... See full document